Investor List:

Top Therapeutics Seed Investors in Los Angeles / Southern California (26)

Know someone who's actively diligencing and investing? Add them to this list.
About this list
We’ve compiled a list of the top Therapeutics investors. The goal is to help Founders find the best investors to target and get introduced to.
Photo of Geoffrey Smith, Managing Partner at Digitalis Ventures
Geoffrey Smith
Digitalis Ventures·Managing Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in New York (NY), Investors in Los Angeles (CA), Investors in San Francisco (CA), Investors in Boston (MA)
Investors in Therapeutics (Series B), Investors in Therapeutics (Series A), Investors in Therapeutics (Seed), Investors in Therapeutics (Series B), Investors in Diagnostics (Series A), Investors in Therapeutics (Series A), Investors in Therapeutics (Series B), Investors in Therapeutics (Series B), Investors in Therapeutics (Series B), Investors in Diagnostics (Series B), Investors in Diagnostics (Series A), Investors in Diagnostics (Seed), Investors in Therapeutics (Seed), Investors in Diagnostics (Series B), Investors in Diagnostics (Seed), Investors in Diagnostics (Series A), Investors in Diagnostics (Series B), Investors in Diagnostics (Seed), Investors in Diagnostics (Series B), Investors in Diagnostics (Series A), Investors in Diagnostics (Series B), Investors in Diagnostics (Series A), Investors in Therapeutics (Seed), Investors in Diagnostics (Seed), Investors in Manufacturing (Series B), Investors in Therapeutics (Series A), Investors in Manufacturing (Series B), Investors in Therapeutics (Series A), Investors in Therapeutics (Series A), Investors in Diagnostics (Seed), Investors in BioTech (Series B), Investors in Therapeutics (Seed), Investors in Therapeutics (Seed), Investors in Manufacturing (Series A), Investors in Manufacturing (Series B), Investors in Digital Health (Series B), Investors in BioTech (Series A), Investors in Digital Health (Series B), Investors in Manufacturing (Series A), Investors in BioTech (Series B), Investors in Manufacturing (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Series A), Investors in Manufacturing (Seed), Investors in Health IT (Series B), Investors in Manufacturing (Series A), Investors in Digital Health (Seed), Investors in Manufacturing (Seed), Investors in Health & Hospital Services (Series B), Investors in Health & Hospital Services (Series B), Investors in Manufacturing (Series B), Investors in Health IT (Series A), Investors in BioTech (Series B), Investors in Health & Hospital Services (Series A), Investors in Health IT (Series B), Investors in Digital Health (Series B), Investors in BioTech (Seed), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Series A), Investors in BioTech (Series A), Investors in Health IT (Series A), Investors in Manufacturing (Series B), Investors in Health & Hospital Services (Seed), Investors in Manufacturing (Series A), Investors in BioTech (Series A), Investors in Health IT (Seed), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series B), Investors in Health & Hospital Services (Seed), Investors in BioTech (Seed), Investors in Digital Health (Series A), Investors in Health IT (Seed), Investors in Manufacturing (Seed), Investors in Manufacturing (Series A), Investors in Digital Health (Seed), Investors in BioTech (Seed), Investors in Digital Health (Series B), Investors in Manufacturing (Seed), Investors in Health IT (Series A), Investors in Health & Hospital Services (Series A), Investors in Digital Health (Series A), Investors in Health & Hospital Services (Seed), Investors in Health IT (Seed), Investors in Digital Health (Seed), Investors in Digital Health (Series B), Investors in BioTech (Series B), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series B), Investors in BioTech (Series B), Investors in Digital Health (Series A), Investors in BioTech (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Series A), Investors in BioTech (Seed), Investors in Health & Hospital Services (Seed), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series B), Investors in Health IT (Series A), Investors in BioTech (Series A), Investors in Health IT (Seed), Investors in BioTech (Seed), Investors in Health & Hospital Services (Series A), Investors in Health & Hospital Services (Seed), Investors in Health IT (Series A), Investors in Health IT (Seed), Investors in Los Angeles / Southern California (Other Lists), Investors in Boston / New England (Other Lists), Investors in New York City (Other Lists), Investors in San Francisco Bay Area (Other Lists)
Photo of Eric Brook, Investor at Prithvi Ventures
Eric Brook
Sweet spot: $750K
Range: $500K - $2.5M
Investors in Los Angeles (CA)
Investors in Drug Delivery (Seed), Investors in Chemicals (Series A), Investors in Drug Delivery (Series A), Investors in Therapeutics (Pre-seed), Investors in Drug Delivery (Pre-seed), Investors in Drug Delivery (Pre-seed), Investors in Drug Delivery (Series A), Investors in Drug Delivery (Seed), Investors in Chemicals (Seed), Investors in Pharmaceuticals (Pre-seed), Investors in Therapeutics (Seed), Investors in Chemicals (Pre-seed), Investors in Therapeutics (Pre-seed), Investors in Pharmaceuticals (Series A), Investors in Therapeutics (Series A), Investors in Pharmaceuticals (Seed), Investors in Chemicals (Pre-seed), Investors in EnergyTech (Series A), Investors in Therapeutics (Series A), Investors in Food and Beverage (Pre-seed), Investors in Chemicals (Series A), Investors in EnergyTech (Pre-seed), Investors in Therapeutics (Seed), Investors in EnergyTech (Seed), Investors in Food and Beverage (Series A), Investors in AgTech (Pre-seed), Investors in Food and Beverage (Seed), Investors in Chemicals (Seed), Investors in ClimateTech/CleanTech (Pre-seed), Investors in BioTech (Pre-seed), Investors in AgTech (Series A), Investors in Pharmaceuticals (Pre-seed), Investors in AgTech (Seed), Investors in ClimateTech/CleanTech (Series A), Investors in Consumer Health (Pre-seed), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in ClimateTech/CleanTech (Seed), Investors in Consumer Health (Series A), Investors in Consumer Health (Seed), Investors in AgTech (Pre-seed), Investors in Pharmaceuticals (Seed), Investors in Pharmaceuticals (Series A), Investors in Food and Beverage (Pre-seed), Investors in EnergyTech (Pre-seed), Investors in Food and Beverage (Series A), Investors in AgTech (Series A), Investors in Consumer Health (Pre-seed), Investors in Food and Beverage (Seed), Investors in EnergyTech (Series A), Investors in AgTech (Seed), Investors in ClimateTech/CleanTech (Pre-seed), Investors in EnergyTech (Seed), Investors in BioTech (Pre-seed), Investors in Consumer Health (Series A), Investors in Consumer Health (Seed), Investors in ClimateTech/CleanTech (Series A), Investors in BioTech (Series A), Investors in ClimateTech/CleanTech (Seed), Investors in BioTech (Seed), Investors in Los Angeles / Southern California (Other Lists), Investors in Investors who invested in female founders (Other Lists), Investors in Investors who invested in diverse founders (Other Lists)
Photo of Samuel Bjork, Partner at Digitalis Ventures
Samuel Bjork
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in New York (NY), Investors in Los Angeles (CA), Investors in San Francisco (CA)
Photo of Fabian Hansen, Managing Director at Presight Capital
Fabian Hansen
Presight Capital·Managing Director
Sweet spot: $10.0M
Range: $500K - $20.0M
Investors in Los Angeles (CA)
Investors in Therapeutics (Seed), Investors in Therapeutics (Series B), Investors in DeepTech (Series B), Investors in Therapeutics (Series A), Investors in Therapeutics (Series B), Investors in DeepTech (Series A), Investors in DeepTech (Seed), Investors in BioTech (Series B), Investors in Consumer Health (Series B), Investors in Health & Hospital Services (Series B), Investors in Therapeutics (Series A), Investors in Health IT (Series B), Investors in Consumer Health (Series A), Investors in Therapeutics (Seed), Investors in Consumer Health (Seed), Investors in FinTech (Series B), Investors in BioTech (Series A), Investors in Health & Hospital Services (Series A), Investors in BioTech (Seed), Investors in DeepTech (Series B), Investors in Health & Hospital Services (Seed), Investors in Health IT (Series A), Investors in Health IT (Seed), Investors in FinTech (Series A), Investors in FinTech (Seed), Investors in Consumer Health (Series B), Investors in DeepTech (Series A), Investors in DeepTech (Seed), Investors in BioTech (Series B), Investors in Consumer Health (Series A), Investors in Health IT (Series B), Investors in Los Angeles / Southern California (Other Lists), Investors in Health & Hospital Services (Series B), Investors in Consumer Health (Seed), Investors in BioTech (Series A), Investors in FinTech (Series B), Investors in BioTech (Seed), Investors in Health & Hospital Services (Seed), Investors in Health & Hospital Services (Series A), Investors in Health IT (Series A), Investors in Health IT (Seed), Investors in FinTech (Seed), Investors in FinTech (Series A)
Photo of Teymour Boutros-Gali, Managing Partner at Bold Capital Partners
Teymour Boutros-Gali
Bold Capital Partners·Managing Partner
Sweet spot: $4.0M
Range: $500K - $10.0M
Investors in Santa Monica (CA)
Investors in Therapeutics (Series A), Investors in Therapeutics (Seed), Investors in Wellness & Fitness (Series A), Investors in Wellness & Fitness (Seed), Investors in DeepTech (Series A), Investors in AR/VR (Series A), Investors in DeepTech (Seed), Investors in IoT (Series A), Investors in AR/VR (Seed), Investors in Therapeutics (Series A), Investors in IoT (Seed), Investors in Digital Health (Seed), Investors in Digital Health (Series A), Investors in BioTech (Series A), Investors in Web3/Blockchain (Series A), Investors in BioTech (Seed), Investors in Therapeutics (Seed), Investors in Consumer Health (Seed), Investors in Web3/Blockchain (Seed), Investors in Consumer Health (Series A), Investors in Wellness & Fitness (Series A), Investors in AI (Series A), Investors in AI (Seed), Investors in Wellness & Fitness (Seed), Investors in AR/VR (Series A), Investors in AR/VR (Seed), Investors in DeepTech (Series A), Investors in DeepTech (Seed), Investors in IoT (Series A), Investors in IoT (Seed), Investors in Consumer Health (Series A), Investors in Web3/Blockchain (Series A), Investors in Consumer Health (Seed), Investors in Digital Health (Series A), Investors in BioTech (Series A), Investors in Digital Health (Seed), Investors in BioTech (Seed), Investors in Web3/Blockchain (Seed), Investors in AI (Series A), Investors in AI (Seed), Investors in Los Angeles / Southern California (Other Lists), Investors in Diverse Investors (Other Lists), Investors in Investors who were founders (Other Lists), Investors in Investors who invested in female founders (Other Lists), Investors in Investors who invested in diverse founders (Other Lists)
Photo of Jason Camm, Managing Director at Thiel Capital
Jason Camm
Thiel Capital·Managing Director
Sweet spot: $1.5M
Range: $100K - $1.5M
Investors in West Hollywood (CA)
Photo of Mark Hahs, Managing Partner at VentureDNA
Mark Hahs
VentureDNA·Managing Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Bakersfield (CA)
Investors in Therapeutics (Seed), Investors in Therapeutics (Series A), Investors in Therapeutics (Series A), Investors in Payments (Series A), Investors in Payments (Seed), Investors in IoT (Series A), Investors in Therapeutics (Seed), Investors in Digital Health (Series A), Investors in IoT (Seed), Investors in Health & Hospital Services (Series A), Investors in Digital Health (Seed), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in Health & Hospital Services (Seed), Investors in Health IT (Series A), Investors in Health IT (Seed), Investors in Payments (Series A), Investors in Payments (Seed), Investors in IoT (Series A), Investors in Digital Health (Seed), Investors in IoT (Seed), Investors in Health IT (Series A), Investors in BioTech (Series A), Investors in Digital Health (Series A), Investors in BioTech (Seed), Investors in Los Angeles / Southern California (Other Lists), Investors in Health & Hospital Services (Series A), Investors in Health & Hospital Services (Seed), Investors in Health IT (Seed)
Photo of Paul Deneys, Vice President at Thiel Capital
Paul Deneys
Thiel Capital·Vice President
Sweet spot: $1.5M
Range: $100K - $1.5M
Investors in West Hollywood (CA)